NuvOx Pharma LLC Announces Authorization of ARDS Trial from Health Canada
Tucson, AZ, July 13, 2024 — NuvOx Pharma LLC (“NuvOx”) announced that it has received authorization from Health Canada for its EXTEND: novEl oXygen ThErapeutic NanO2 for mild respiratory distress in Phase Ib and ARDS…